These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27423327)

  • 1. Plaque-penetrating peptide inhibits development of hypoxic atherosclerotic plaque.
    She ZG; Hamzah J; Kotamraju VR; Pang HB; Jansen S; Ruoslahti E
    J Control Release; 2016 Sep; 238():212-220. PubMed ID: 27423327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice.
    Hamzah J; Kotamraju VR; Seo JW; Agemy L; Fogal V; Mahakian LM; Peters D; Roth L; Gagnon MK; Ferrara KW; Ruoslahti E
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7154-9. PubMed ID: 21482787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in LyP-1-based strategies for targeted imaging and therapy.
    Song N; Zhao L; Zhu M; Zhao J
    Drug Deliv; 2019 Dec; 26(1):363-375. PubMed ID: 30905205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.
    Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W
    Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice.
    Kyaw T; Winship A; Tay C; Kanellakis P; Hosseini H; Cao A; Li P; Tipping P; Bobik A; Toh BH
    Circulation; 2013 Mar; 127(9):1028-39. PubMed ID: 23395974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice.
    Singla DK; Singla R; Wang J
    PLoS One; 2016; 11(1):e0147897. PubMed ID: 26824441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaque.
    Seo JW; Baek H; Mahakian LM; Kusunose J; Hamzah J; Ruoslahti E; Ferrara KW
    Bioconjug Chem; 2014 Feb; 25(2):231-9. PubMed ID: 24433095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques.
    Benne N; Martins Cardoso R; Boyle AL; Kros A; Jiskoot W; Kuiper J; Bouwstra J; Van Eck M; Slütter B
    Adv Healthc Mater; 2020 May; 9(10):e2000043. PubMed ID: 32329226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1.
    Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y
    Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
    Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
    Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese medication Tongxinluo attenuates apoptosis in ox-LDL-stimulated macrophages by enhancing Beclin-1-induced autophagy.
    Chen Y; Li M; Zhang Y; Di M; Chen W; Liu X; Yu F; Wang H; Zhen X; Zhang M
    Biochem Biophys Res Commun; 2018 Jun; 501(2):336-342. PubMed ID: 29550482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spermidine reduces lipid accumulation and necrotic core formation in atherosclerotic plaques via induction of autophagy.
    Michiels CF; Kurdi A; Timmermans JP; De Meyer GRY; Martinet W
    Atherosclerosis; 2016 Aug; 251():319-327. PubMed ID: 27450786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
    J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.